Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study
Related Articles
Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (FTD) are underway, but sensitive cognitive outcome measures are lacking. The aim of this study…
Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and the Diagnostic Interval in Breast and Colorectal Cancer
Background and Objectives The multiple sclerosis (MS) population’s survival from breast cancer and colorectal cancer is compromised. Cancer screening and timely diagnoses affect cancer survival…
Levels of Neurofilament Light at the Preataxic and Ataxic Stages of Spinocerebellar Ataxia Type 1
Background and Objectives Neurofilament light (NfL) appears to be a promising fluid biomarker in repeat-expansion spinocerebellar ataxias (SCAs), with piloting studies in mixed SCA cohorts…
Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes
We appreciate the interest in our research1 of subthalamic nucleus (STN) deep brain stimulation (DBS) in early-stage Parkinson disease (PD). As noted in our publication,…
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study
Objectives To evaluate white matter and grey matter T1-weighted (w)/T2w ratio (T1w/T2w ratio) in healthy controls and patients with multiple sclerosis, and its association with…
English
العربية
简体中文
Nederlands
Français
Deutsch
Italiano
Português
Русский
Español
Responses